MaRS Innovation portfolio company completing Phase 1 human clinical trial of drug to prevent dermal scarring VANCOUVER (February 16, 2016) — Accel-Rx Health Sciences Accelerator (Accel-Rx), a Centre of Excellence…
VitalHub’s partnership with Microsoft and Intel for Seattle Children’s Hospital pilot and British Columbia contracts featured in Canadian Healthcare Technology
“As hospital invest continue to invest in mobile solutions, doctors and nurses are more likely to be texting on their smartphones or swiping their fingers across a tablet PCs than tapping away on desktop computers,” Dianne Daniel writes in the April 2015 issue of Canadian Healthcare Technology in an article titled, “Smartphones and mobile tablets are becoming essential tools for clinicians” (page 12-13 of the print edition).
VitalHub Corp, a Mount Sinai Hospital spun-off through partnership with MaRS Innovation, is among the healthcare technology companies delivering services to hospitals as part of this trend.
One company that is giving clinicians the option to use their preferred device — whether iOS, Android, or Windows 8, smartphone or tablet — is VitalHub Corp, a Mount Sinai spin-off launched in Toronto in 2009. “We have found that many hospitals provide their nurses with mobile devices and can therefore select the platform they would prefer for those users, but physicians are generally expected to be BOD,” said VitalHub CEO Lisa Crossley. “So for a mobile solution to be practical, it has to be cross-platform.”
Jeff Cates’ op-ed in the Globe and Mail‘s Small Business/Digital Innovation section on June 19, 2014 argues that incubators have a key role to play in fostering innovation, entrepreneurship and growing new industries in Ontario.
Cates states this is particularly true when incubators when they provide programs and services to help young entrepreneurs succeed.
The University of Toronto Early-Stage Technology program (UTEST), co-managed with MaRS Innovation, is one such program. UTEST is set to announce its third cohort within the next month.
The article by Joseph Czikk, BetaKit’s managing editor, is part of a series on Canada’s most promising start-up accelerators and the people who make them successful. Czikk highlights UTEST “as one of the most value-packed programs in the entire country” and credits the calibre of applicants and ideas to the program’s requirement to have at least one co-founder affiliated to the University of Toronto.
UTEST is now accepting applications for the program’s third cohort. Those interested should watch for updates through MaRS Innovation and the University of Toronto, or contact UTEST co-directors Mike Betts and Kurtis Scissons for more information.
MISSISSAUGA, Ontario, September 18, 2012 – CML HealthCare Inc. (TSX: CLC) (the “Company” or “CML”) and MaRS Innovation (MI), a Centre of Excellence for Commercialization and Research, have entered into a strategic partnership to commercialize early-stage technologies that present innovative methods in medical diagnostics.
This story was covered in the Globe and Mail, Canadian Business, 680 News, Reuters, Sympatico.ca, the Huffington Post Canada, Technology Trasnfer Tactics, and the Winnipeg Free Press, among others. It was distributed via Yahoo! Finance, Healthcare Global.com, marketwire and Digital Journal.
Raphael Hofstein, president and CEO of MaRS Innovation, was interviewed by Huffington Post Canada business reporter Rachel Mendleson for an article about Canada’s innovation gap and the shortage of Canadian venture capital:
One of the best ways to [raise venture capital], said Raphael Hofstein, President and CEO of Toronto-based MaRS Innovation, is to increase government investment, a lesson he learned while helping to create a life sciences early-stage fund in Israel several years ago.
“Everybody told us — institutions, industry — that they will not participate unless government has a piece of the pie. So governments have to participate, certainly in the early stage,” he said.